Geodesic diameter of sets defined by few quadratic equations and inequalities

M. Coste,Seydou Moussa

DOI: https://doi.org/10.1007/s00209-011-0931-6

2010-09-02

Abstract:

What problem does this paper attempt to address?

KCNH2-3.1 Mediates Aberrant Complement Activation and Impaired Hippocampal-Medial Prefrontal Circuitry Associated with Working Memory Deficits.

Ming Ren,Zhonghua Hu,Qiang Chen,Andrew Jaffe,Yingbo Li,Vijay Sadashivaiah,Shujuan Zhu,Nina Rajpurohit,Joo Heon Shin,Wei Xia,Yankai Jia,Jingxian Wu,Sunny Lang Qin,Xinjian Li,Jian Zhu,Qingjun Tian,Daniel Paredes,Fengyu Zhang,Kuan Hong Wang,Venkata S. Mattay,Joseph H. Callicott,Karen F. Berman,Daniel R. Weinberger,Feng Yang

DOI: https://doi.org/10.1038/s41380-019-0530-1

IF: 11

2019-01-01

Molecular Psychiatry

Abstract:Increased expression of the 3.1 isoform of the KCNH2 potassium channel has been associated with cognitive dysfunction and with schizophrenia, yet little is known about the underlying pathophysiological mechanisms. Here, by using in vivo wireless local field potential recordings during working memory processing, in vitro brain slice whole-cell patching recordings and in vivo stereotaxic hippocampal injection of AAV-encoded expression, we identified specific and delayed disruption of hippocampal-mPFC synaptic transmission and functional connectivity associated with reductions of SERPING1, CFH , and CD74 in the KCNH2-3.1 overexpression transgenic mice. The differentially expressed genes in mice are enriched in neurons and microglia, and reduced expression of these genes dysregulates the complement cascade, which has been previously linked to synaptic plasticity. We find that knockdown of these genes in primary neuronal–microglial cocultures from KCNH2-3.1 mice impairs synapse formation, and replenishing reduced CFH gene expression rescues KCNH2-3.1-induced impaired synaptogenesis. Translating to humans, we find analogous dysfunctional interactions between hippocampus and prefrontal cortex in coupling of the fMRI blood oxygen level-dependent (BOLD) signal during working memory in healthy subjects carrying alleles associated with increased KCNH2-3.1 expression in brain. Our data uncover a previously unrecognized role of the truncated KCNH2-3.1 potassium channel in mediating complement activation, which may explain its association with altered hippocampal–prefrontal connectivity and synaptic function. These results provide a potential molecular link between increased KCNH2-3.1 expression, synapse alterations, and hippocampal–prefrontal circuit abnormalities implicated in schizophrenia.
Etiological involvement of KCND1 variants in an X-linked neurodevelopmental disorder with variable expressivity

Tassja Kalm,Claudia Schob,Hanna Völler,Thatjana Gardeitchik,Christian Gilissen,Rolph Pfundt,Chiara Klöckner,Konrad Platzer,Annick Klabunde-Cherwon,Markus Ries,Steffen Syrbe,Francesca Beccaria,Francesca Madia,Marcello Scala,Federico Zara,Floris Hofstede,Marleen E.H. Simon,Richard H. van Jaarsveld,Renske Oegema,Koen L.I. van Gassen,Sjoerd J.B. Holwerda,Tahsin Stefan Barakat,Arjan Bouman,Marjon van Slegtenhorst,Sara Álvarez,Alberto Fernández-Jaén,Javier Porta,Andrea Accogli,Margherita Maria Mancardi,Pasquale Striano,Michele Iacomino,Jong-Hee Chae,SeSong Jang,Soo Y. Kim,David Chitayat,Saadet Mercimek-Andrews,Christel Depienne,Antje Kampmeier,Alma Kuechler,Harald Surowy,Enrico Silvio Bertini,Francesca Clementina Radio,Cecilia Mancini,Simone Pizzi,Marco Tartaglia,Lucas Gauthier,David Genevieve,Mylène Tharreau,Noy Azoulay,Gal Zaks-Hoffer,Nesia K. Gilad,Naama Orenstein,Geneviève Bernard,Isabelle Thiffault,Jonas Denecke,Theresia Herget,Fanny Kortüm,Christian Kubisch,Robert Bähring,Stefan Kindler

DOI: https://doi.org/10.1016/j.ajhg.2024.04.019

2024-06-07

The American Journal of Human Genetics

Abstract:Hemizygous variants of KCND1 lead to alterations in the biophysical properties of the encoded ion channel, implicating dysfunction of Kv4.1 voltage-gated potassium channels in the etiology of an X-linked neurodevelopmental disorder with variable expressivity.

genetics & heredity
Koolen-de Vries Syndrome causal gene is required for motile ciliogenesis

James D. Schmidt,Ananya Terala,Kate E. McCluskey,Belinda Wang,Anna C. Pfalzer,Helen Rankin Willsey

DOI: https://doi.org/10.1101/2024.11.14.621349

2024-11-14

Abstract:Koolen-de Vries Syndrome (KdVS), characterized by hypersociability, intellectual disability, and seizures, is caused by pathogenic variants in the gene , which encodes a chromatin regulator in the NSL complex that also directly functions in mitotic spindle microtubule stability. Here we explored whether KANSL1 functions at the cilium, a microtubule-rich organelle critical for brain development, neuronal excitability, and sensory integration. Leveraging the model, we found that Kansl1 is highly expressed in developing ciliated tissues and localizes within motile cilia. Moreover, depletion caused ciliogenesis defects that could be partially rescued by human . Based on these findings, we explored the prevalence of cilia-related clinical features including structural heart defects, hypogonadism, and structural respiratory defects among 99 individuals with KdVS, ages 1 month to 37 years old. To directly test if KdVS causes ciliary dysfunction in humans, we measured the well-established ciliary functional biomarker, nasal nitric oxide, in 11 affected individuals and observed a significant decrease when compared to unaffected family members. Together, this work establishes a ciliary contribution of mutations to KdVS. This work adds to a growing literature highlighting the relevance of the cilium to neurodevelopmental disorders, particularly to those impacting sociability. Going forward, KANSL1 provides a unique opportunity to study a monogenic mechanism of hypersociability that may be useful in elaborating the molecular underpinnings of social behavior.

Developmental Biology
An Epilepsy-Associated CILK1 Variant Compromises KATNIP Regulation and Impairs Primary Cilia and Hedgehog Signaling

Ana Limerick,Ellie A. McCabe,Jacob S. Turner,Kevin W. Kuang,David L. Brautigan,Yi Hao,Cheuk Ying Chu,Sean H. Fu,Sean Ahmadi,Wenhao Xu,Zheng Fu

DOI: https://doi.org/10.3390/cells13151258

IF: 6

2024-07-27

Cells

Abstract:Mutations in human CILK1 (ciliogenesis associated kinase 1) are linked to ciliopathies and epilepsy. Homozygous point and nonsense mutations that extinguish kinase activity impair primary cilia function, whereas mutations outside the kinase domain are not well understood. Here, we produced a knock-in mouse equivalent to the human CILK1 A615T variant identified in juvenile myoclonic epilepsy (JME). This residue is in the intrinsically disordered C-terminal region of CILK1 separate from the kinase domain. Mouse embryo fibroblasts (MEFs) with either heterozygous or homozygous A612T mutant alleles exhibited a higher ciliation rate, shorter individual cilia, and upregulation of ciliary Hedgehog signaling. Thus, a single A612T mutant allele was sufficient to impair primary cilia and ciliary signaling in MEFs. Gene expression profiles of wild-type versus mutant MEFs revealed profound changes in cilia-related molecular functions and biological processes. The CILK1 A615T mutant protein was not increased to the same level as the wild-type protein when co-expressed with scaffold protein KATNIP (katanin-interacting protein). Our data show that KATNIP regulation of a JME-associated single-residue variant of CILK1 is compromised, and this impairs the maintenance of primary cilia and Hedgehog signaling.

cell biology
KCNT2-Related Disorders: Phenotypes, Functional, and Pharmacological Properties

Maria Cristina Cioclu,Ilaria Mosca,Paolo Ambrosino,Deborah Puzo,Allan Bayat,Saskia B Wortmann,Johannes Koch,Vincent Strehlow,Kentaro Shirai,Naomichi Matsumoto,Stephan J Sanders,Vincent Michaud,Marine Legendre,Antonella Riva,Pasquale Striano,Hiltrud Muhle,Manuela Pendziwiat,Gaetan Lesca,Giuseppe Donato Mangano,Rosaria Nardello,KCNT2-study group,Johannes R Lemke,Rikke S Møller,Maria Virginia Soldovieri,Guido Rubboli,Maurizio Taglialatela,Ilenio Servettini,Giorgio Belperio,Erik-Jan Kamsteeg,Koji Takahashi,Satomi Mitsuhashi,Elizabeth E Palmer,Ann M Bye,Irene Madrigal,Maria Isabel Alvarez-Mora,Aurora Sánchez,Stefano Meletti,Ingo Helbig,Pauline Le Tanno,Bénédicte Gerard,Salima El Chehadeh

DOI: https://doi.org/10.1002/ana.26662

Abstract:Objective: Pathogenic variants in KCNT2 are rare causes of developmental epileptic encephalopathy (DEE). We herein describe the phenotypic and genetic features of patients with KCNT2-related DEE, and the in vitro functional and pharmacological properties of KCNT2 channels carrying 14 novel or previously untested variants. Methods: Twenty-five patients harboring KCNT2 variants were investigated: 12 were identified through an international collaborative network, 13 were retrieved from the literature. Clinical data were collected and included in a standardized phenotyping sheet. Novel variants were detected using exome sequencing and classified using ACMG criteria. Functional and pharmacological studies were performed by whole-cell electrophysiology in HEK-293 and SH-SY5Y cells. Results: The phenotypic spectrum encompassed: (a) intellectual disability/developmental delay (21/22 individuals with available information), ranging from mild to severe/profound; (b) epilepsy (15/25); (c) neurological impairment, with altered muscle tone (14/22); (d) dysmorphisms (13/20). Nineteen pathogenic KCNT2 variants were found (9 new, 10 reported previously): 16 missense, 1 in-frame deletion of a single amino acid, 1 nonsense, and 1 frameshift. Among tested variants, 8 showed gain-of-function (GoF), and 6 loss-of-function (LoF) features when expressed heterologously in vitro. Quinidine and fluoxetine blocked all GoF variants, whereas loxapine and riluzole activated some LoF variants while blocking others. Interpretation: We expanded the phenotypic and genotypic spectrum of KCNT2-related disorders, highlighting novel genotype-phenotype associations. Pathogenic KCNT2 variants cause GoF or LoF in vitro phenotypes, and each shows a unique pharmacological profile, suggesting the need for in vitro functional and pharmacological investigation to enable targeted therapies based on the molecular phenotype. ANN NEUROL 2023;94:332-349.
A KCNC1 Variant Linked to Rett Syndrome Disrupts ER to Golgi Trafficking of Kv3.1 Channel

Diego Maureira,Carla Rubilar,Joaquin Lopez,Paola Santander,Hans Moldenhauer,Ian Silva,Pablo Cruz,Denise Riquelme,Javiera Baeza,Wendy Gonzalez,Patricio Orio,Evrim Servili,Monica Troncoso,Elias Leiva-Salcedo,Oscar Cerda

DOI: https://doi.org/10.1101/2024.11.12.623225

2024-11-13

Abstract:Intrinsic neuronal excitability, defined by the balance between input and output signals, is crucial to neural function, and its disruption underlies various neurological diseases. Kv3.1 channels, encoded by KCNC1, are essential for high-frequency action potential firing. Variants in these channels are associated with several subtypes of epilepsy. We report a patient with developmental regression and epilepsy, meeting Rett syndrome criteria, who carries a KCNC1 variant encoding the S474C substitution in Kv3.1 (Kv3.1S474C). Electrophysiological and biochemical assays reveal that Kv3.1S474C reduces channel presence in the plasma membrane and is retained in the endoplasmic reticulum (ER). In murine primary cultures expressing Kv3.1S474C, we observed reduced neuronal firing frequency and exclusion of the channel from the axon initial segment (AIS). Consistently, we found a decreased firing frequency using a conductance-based computational neuronal model. In summary, this study identifies a novel link between a KCNC1 variant and Rett syndrome, highlighting the importance of S474 residue in Kv3.1 channel trafficking and function in neurons.

Cell Biology
Patients with KCNH1-related intellectual disability without distinctive features of Zimmermann-Laband/Temple-Baraitser syndrome

Marion Aubert Mucca,Olivier Patat,Sandra Whalen,Lionel Arnaud,Giulia Barcia,Julien Buratti,Benjamin Cogné,Diane Doummar,Caroline Karsenty,Sandra Kenis,Eric Leguern,Gaetan Lesca,Caroline Nava,Mathilde Nizon,Amelie Piton,Stéphanie Valence,Laurent Villard,Sarah Weckhuysen,Boris Keren,Cyril Mignot

DOI: https://doi.org/10.1136/jmedgenet-2020-107511

Abstract:De novo missense variants in KCNH1 encoding Kv10.1 are responsible for two clinically recognisable phenotypes: Temple-Baraitser syndrome (TBS) and Zimmermann-Laband syndrome (ZLS). The clinical overlap between these two syndromes suggests that they belong to a spectrum of KCNH1-related encephalopathies. Affected patients have severe intellectual disability (ID) with or without epilepsy, hypertrichosis and distinctive features such as gingival hyperplasia and nail hypoplasia/aplasia (present in 20/23 reported cases).We report a series of seven patients with ID and de novo pathogenic KCNH1 variants identified by whole-exome sequencing or an epilepsy gene panel in whom the diagnosis of TBS/ZLS had not been first considered. Four of these variants, p.(Thr294Met), p.(Ala492Asp), p.(Thr493Asn) and p.(Gly496Arg), were located in the transmembrane domains S3 and S6 of Kv10.1 and one, p.(Arg693Gln), in its C-terminal cyclic nucleotide-binding homology domain (CNBHD). Clinical reappraisal by the referring clinical geneticists confirmed the absence of the distinctive gingival and nail features of TBS/ZLS.Our study expands the phenotypical spectrum of KCNH1-related encephalopathies to individuals with an attenuated extraneurological phenotype preventing a clinical diagnosis of TBS or ZLS. This subtype may be related to recurrent substitutions of the Gly496, suggesting a genotype-phenotype correlation and, possibly, to variants in the CNBHD domain.
Abdominal Pregnancy: Discussion, classification, and case presentation

W. F. Baldwin

1954-10-01

Abstract:
CONSTITUTIVE OPENING OF THE Kv7.2 PORE ACTIVATION GATE CAUSES KCNQ2-DEVELOPMENTAL ENCEPHALOPATHY

Mario Nappi,Giulio Alberini,Alessandro Berselli,Agnese Roscioni,Maria Virginia Soldovieri,Vincenzo Barrese,Sarah Weckhuysen,Ting-Gee Annie Chiu,Ingrid E Scheffer,Fabio Benfenati,Luca Maragliano,Francesco Miceli,Maurizio Taglialatela

DOI: https://doi.org/10.1101/2024.05.20.593680

2024-05-21

Abstract:Pathogenic variants in KCNQ2 encoding for Kv7.2 voltage-gated potassium channel subunits cause developmental encephalopathies (KCNQ2-encephalopathies), both with and without epilepsy. We herein describe the clinical, in vitro and in silico features of two encephalopathy-causing variants (A317T, L318V) in Kv7.2 affecting two consecutive residues in the S6> activation gate undergoing large structural rearrangements during pore opening. Currents through these mutant channels displayed increased density, hyperpolarizing shifts in activation gating, and insensitivity to phosphatidylinositol 4,5-bisphosphate (PIP2), a critical regulator of Kv7 channel function; all these features are consistent with a strong gain-of-function effect. An increase in single-channel open probability, with no change in membrane abundance or single-channel conductance, was responsible for the observed gain-of-function effects. All-atoms Molecular Dynamics simulations revealed that the mutations widened the inner pore gate and stabilized a constitutively open channel configuration in the closed state, with minimal effects on the open conformation. Thus, a PIP2-independent stabilization of the inner pore gate open configuration is a novel molecular pathogenetic mechanism for KCNQ2-developmental encephalopathies.

Biology
Genetic and phenotypic heterogeneity in KIAA0753-related ciliopathies

Katherine A Inskeep,Yuri A Zarate,Danielle Monteil,Jurgen Spranger,Dan Doherty,Rolf W Stottmann,K Nicole Weaver

DOI: https://doi.org/10.1002/ajmg.a.62497

Abstract:Primary ciliopathies are heterogenous disorders resulting from perturbations in primary cilia form and/or function. Primary cilia are cellular organelles which mediate key signaling pathways during development, such as the sonic hedgehog (SHH) pathway which is required for neuroepithelium and central nervous system development. Joubert syndrome is a primary ciliopathy characterized by cerebellar/brain stem malformation, hypotonia, and developmental delays. At least 35 genes are associated with Joubert syndrome, including the gene KIAA0753, which is part of a complex required for primary ciliogenesis. The phenotypic spectrum associated with biallelic pathogenic variants in KIAA0753 is broad and not well-characterized. We describe four individuals with biallelic pathogenic KIAA0753 variants, including five novel variants. We report in vitro results assessing the function of each variant indicating that mutant proteins are not fully competent to promote primary ciliogenesis. Ablation of KIAA0753 in vitro blocks primary ciliogenesis and SHH pathway activity. Correspondingly, KIAA0753 patient fibroblasts have a deficit in primary ciliation and improper SHH and WNT signaling, with a particularly blunted response to SHH pathway stimulation. Our work expands the phenotypic spectrum of KIAA0753 ciliopathies and demonstrates the utility of patient-focused functional assays for proving causality of genetic variants.
Asymmetric Michael reactions catalyzed by a highly efficient and recyclable quaternary ammonium ionic liquid-supported organocatalyst in aqueous media.

Subrata K. Ghosh,Y. Qiao,Bukuo Ni,A. Headley

DOI: https://doi.org/10.1039/c3ob27398a

2013-02-22

Abstract:A novel ionic liquid-support organocatalyst, which contains the quaternary ammonium ion moiety, was recently developed and successfully applied to the asymmetric Michael reaction in the presence of a newly developed ionic liquid-supported (ILS) benzoic acid as co-catalyst. For the reactions studied, in which various aldehydes and nitroolefins were examined, excellent diastereo- and enantioselectivities were obtained with low catalyst loading. Also, the catalyst could be recycled for ten times without significant loss of enantioselectivity.
Altered neurological and neurobehavioral phenotypes in a mouse model of the recurrent KCNB1-p.R306C voltage-sensor variant

Seok Kyu Kang,Nicole A Hawkins,Christopher H Thompson,Erin M Baker,Dennis M Echevarria-Cooper,Levi Barse,Tyler Thenstedt,Conor J Dixon,Nathan Speakes,Alfred L George,Jennifer A Kearney,Nicole A. Hawkins,Christopher H. Thompson,Erin M. Baker,Dennis M. Echevarria-Cooper,Conor J. Dixon,Alfred L. George,Jennifer A. Kearney

DOI: https://doi.org/10.1016/j.nbd.2024.106470

IF: 7.046

2024-05-01

Neurobiology of Disease

Abstract:Pathogenic variants in KCNB1 are associated with a neurodevelopmental disorder spectrum that includes global developmental delays, cognitive impairment, abnormal electroencephalogram (EEG) patterns, and epilepsy with variable age of onset and severity. Additionally, there are prominent behavioral disturbances, including hyperactivity, aggression, and features of autism spectrum disorder. The most frequently identified recurrent variant is KCNB1-p.R306C, a missense variant located within the S4 voltage-sensing transmembrane domain. Individuals with the R306C variant exhibit mild to severe developmental delays, behavioral disorders, and a diverse spectrum of seizures. Previous in vitro characterization of R306C described altered sensitivity and cooperativity of the voltage sensor and impaired capacity for repetitive firing of neurons. Existing Kcnb1 mouse models include dominant negative missense variants, as well as knockout and frameshifts alleles. While all models recapitulate key features of KCNB1 encephalopathy, mice with dominant negative alleles were more severely affected. In contrast to existing loss-of-function and dominant-negative variants, KCNB1-p.R306C does not affect channel expression, but rather affects voltage-sensing. Thus, modeling R306C in mice provides a novel opportunity to explore impacts of a voltage-sensing mutation in Kcnb1. Using CRISPR/Cas9 genome editing, we generated the Kcnb1<sup>R306C</sup> mouse model and characterized the molecular and phenotypic effects. Consistent with the in vitro studies, neurons from Kcnb1<sup>R306C</sup> mice showed altered excitability. Heterozygous and homozygous R306C mice exhibited hyperactivity, altered susceptibility to chemoconvulsant-induced seizures, and frequent, long runs of slow spike wave discharges on EEG, reminiscent of the slow spike and wave activity characteristic of Lennox Gastaut syndrome. This novel model of channel dysfunction in Kcnb1 provides an additional, valuable tool to study KCNB1 encephalopathies. Furthermore, this allelic series of Kcnb1 mouse models will provide a unique platform to evaluate targeted therapies.

neurosciences
Metabolism of 12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid (12(R)-HETE) in corneal tissues: formation of novel metabolites.

M. Nishimura,M. Schwartzman,J. Falck,S. Lumin,J. Zirrolli,R. Murphy

DOI: https://doi.org/10.1016/0003-9861(91)90548-W

IF: 4.114

1991-11-01

Archives of Biochemistry and Biophysics

Abstract:
Improved classification and pathogenicity assessment by comprehensive functional studies in a large data set of KCNQ2 variants

Yuwei Zhang,Yuqing Xue,Yu Ma,Xiaonan Du,Boxun Lu,Yi Wang,Zhiqiang Yan

DOI: https://doi.org/10.1016/j.lfs.2023.122378

IF: 6.78

2023-12-24

Life Sciences

Abstract:Aims The paucity of functional annotations on hundreds of KCNQ2 variants impedes the diagnosis and treatment of KCNQ2 -related disorders. The aims of this work were to determine the functional properties of 331 clinical KCNQ2 variants, interpreted the pathogenicity of 331 variants using functional data,and explored the association between homomeric channel functions and phenotypes. Main methods We collected 145 KCNQ2 variants from 232 epilepsy patients and 186 KCNQ2 missense variants from the ClinVar database. Whole-cell patch-clamp recording was used to classify the function of 331 variants. Subsequently, we proposed 24 criteria for the pathogenicity interpretation of KCNQ2 variants and used them to assess pathogenicity of 331 variants. Finally, we analyzed the clinical phenotypes of patients carrying these variants, and explored the correlations between functional mechanisms and phenotypes. Key findings In the homozygous state, 287 were classified as loss-of-function and 14 as gain-of-function. In the more clinically relative heterozygous state, 200 variants exhibited functional impairment, 121 of which showed dominant-negative effects on wild-type KCNQ2 subunits. After introducing functional data as strong-level evidence to interpret pathogenicity, over half of variants (169/331) were reclassified and 254 were classified as pathogenic/likely pathogenic. Moreover, dominant-negative effect and haploinsufficiency were identified as primary mechanisms in DEE/ID and SeLNE, respectively. The degree of impairment of channel function correlated with the phenotype severity. Significance Our study reveals the possible cause of KCNQ2 -related disorders at the molecular level, provides compelling evidence for clinical classification of KCNQ2 variants, and expands the knowledge of correlations between functional mechanisms and phenotypes.

pharmacology & pharmacy,medicine, research & experimental
Both Gain- and Loss-of-function Variants of KCNA1 Are Associated with Paroxysmal Kinesigenic Dyskinesia.

Wan-Bing Sun,Jing-Xin Fu,Yu-Lan Chen,Hong-Fu Li,Zhi-Ying Wu,Dian-Fu Chen

DOI: https://doi.org/10.1016/j.jgg.2024.03.013

IF: 5.723

2024-01-01

Journal of Genetics and Genomics

Abstract:KCNA1 is the coding gene for Kv1.1 voltage-gated potassium-channel a subunit. Three variants of KCNA1 have been reported to manifest as paroxysmal kinesigenic dyskinesia (PKD), but the correlation between them remains unclear due to the phenotypic complexity of KCNA1 variants as well as the rarity of PKD cases. Using the whole exome sequencing followed by Sanger sequencing, we screen for potential pathogenic KCNA1 variants in patients clinically diagnosed with paroxysmal movement disorders and identify three previously unreported missense variants of KCNA1 in three unrelated Chinese families. The proband of one family (c.496G>A, p.A166T) manifests as episodic ataxia type 1, and the other two (c.877G>A, p.V293I and c.1112C>A, p.T371A) manifest as PKD. The pathogenicity of these variants is confirmed by functional studies, suggesting that p.A166T and p.T371A cause a loss-of-function of the channel, while p.V293I leads to a gain-of-function with the property of voltage-dependent gating and activation kinetic affected. By reviewing the locations of PKD-manifested KCNA1 variants in Kv1.1 protein, we find that these variants tend to cluster around the pore domain, which is similar to epilepsy. Thus, our study strengthens the correlation between KCNA1 variants and PKD and provides more information on genotype-phenotype correlations of KCNA1 channelopathy. Copyright (c) 2024, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press. All rights reserved.
NEK1 haploinsufficiency impairs ciliogenesis in human iPSC-derived motoneurons and brain organoids

Sorce Marta Nice,Invernizzi Sabrina,Casiraghi Valeria,Santangelo Serena,Lattuada Chiara,Podini Paola,Brusati Alberto,Silva Alessio,Peverelli Silvia,Quattrini Angelo,Silani Vincenzo,Bossolasco Patrizia,Ratti Antonia

DOI: https://doi.org/10.1101/2024.02.29.582696

2024-03-02

Abstract:Primary cilia are microtubule-based organelles acting as specialized signalling antennae that respond to specific stimuli to maintain cellular integrity and homeostasis. Recent studies indicate defective primary cilia in post-mortem human brains and animal models of neurodegenerative conditions, including Amyotrophic Lateral Sclerosis (ALS). Heterozygous loss-of-function mutations (LOF) in gene are present in about 1% of familial and sporadic ALS cases. The protein kinase NEK1 regulates various cellular processes, including ciliogenesis, but a clear link between LOF mutation in ALS and primary cilia is unknown. In this study we generated a human iPSC line carrying a LOF mutation by gene editing, leading to NEK1 protein haploinsufficiency. In differentiated iPSC-motoneurons (MNs) we observed that primary cilia were significantly shorter in -LOF iPSC-MNs compared to wild-type (WT) iPSC-MNs and that also the percentage of ciliated iPSC-MNs was significantly decreased in -LOF cells. We also investigated ciliogenesis in -LOF iPSC-brain organoids confirming that primary cilia were thinner with no apparent alteration in the ultrastructure by transmission electron microscopy. Our data suggest that NEK1 protein plays a role in regulating ciliogenesis in both 2D and 3D human iPSC-derived neuronal models and that LOF mutations associated to ALS, leading to haploinsufficiency and likely to reduced kinase activity, impair primary cilium formation. The involvement of ciliogenesis dysfunction in ALS deserves further investigation providing novel therapeutic targets and strategies to be addressed for this incurable disease.

Neuroscience
Kctd7 deficiency induces myoclonic seizures associated with Purkinje cell death and microvascular defects

Justine H Liang,Jonathan Alevy,Viktor Akhanov,Ryan Seo,Cory A Massey,Danye Jiang,Joy Zhou,Roy V Sillitoe,Jeffrey L Noebels,Melanie A Samuel

DOI: https://doi.org/10.1242/dmm.049642

2022-09-01

Abstract:Mutations in the potassium channel tetramerization domain-containing 7 (KCTD7) gene are associated with a severe neurodegenerative phenotype characterized by childhood onset of progressive and intractable myoclonic seizures accompanied by developmental regression. KCTD7-driven disease is part of a large family of progressive myoclonic epilepsy syndromes displaying a broad spectrum of clinical severity. Animal models of KCTD7-related disease are lacking, and little is known regarding how KCTD7 protein defects lead to epilepsy and cognitive dysfunction. We characterized Kctd7 expression patterns in the mouse brain during development and show that it is selectively enriched in specific regions as the brain matures. We further demonstrate that Kctd7-deficient mice develop seizures and locomotor defects with features similar to those observed in human KCTD7-associated diseases. We also show that Kctd7 is required for Purkinje cell survival in the cerebellum and that selective degeneration of these neurons is accompanied by defects in cerebellar microvascular organization and patterning. Taken together, these results define a new model for KCTD7-associated epilepsy and identify Kctd7 as a modulator of neuron survival and excitability linked to microvascular alterations in vulnerable regions.
Familial KCNQ2 mutation: a psychiatric perspective

Anton Iftimovici,Angeline Charmet,Béatrice Desnous,Ana Ory,Richard Delorme,Charles Coutton,Françoise Devillard,Mathieu Milh,Anna Maruani

DOI: https://doi.org/10.1097/ypg.0000000000000360

2024-01-08

Psychiatric Genetics

Abstract:KCNQ2 mutations can lead to a range of heterogeneous early-onset epileptic syndromes, from self-limited familial neonatal epilepsy to severe neonatal-onset developmental and epileptic encephalopathy. Additional features may include dystonia, spasticity, cortical visual impairment, abnormal eye movements, or feeding intolerance ( Morrison-Levy et al., 2021 ). KCNQ2 is one among the genes coding for KCNQ M-current potassium channels that assemble as heteromers, controlling adaptation of neuronal firing and spike frequency across the brain ( Delmas and Brown, 2005 ; Soh et al., 2022 ). The overall incidence of KCNQ2 -related disorders is estimated at 2.93–3.59 per 100 000 births ( López-Rivera et al., 2020 ). Functional outcome is highly variable with different patterns of seizure activity (some subsequently affecting brain maturation) on the one hand, and altered neurodevelopment on the other, independently of epilepsy. Moreover, different mutations of the KCNQ2 gene can cause the same phenotype ( Milh et al., 2016 ). In this context of heterogeneous genotype/phenotype relationships, the spectrum of KCNQ2 -related neurodevelopment extends from normal cognition to severe motor, behavioral and social impairment ( Symonds et al., 2019 ). However, although the available literature draws an increasingly clearer picture of the various epileptic syndromes and developmental profiles, there is a need to improve our understanding of the socio-behavioral aspects of the disease to inform and prepare families and caregivers. This is especially important in the long-term as seizure frequency usually declines or recedes after childhood, while a high frequency of autistic features and mild to severe intellectual disability (ID) are reported among adults with KCNQ2 encephalopathy ( Boets et al., 2022 ).

genetics & heredity,neurosciences
Plural molecular and cellular mechanisms of pore domain KCNQ2 encephalopathy

Timothy J. Abreo,Emma C. Thompson,Anuraag Madabushi,Heun Soh,Nissi Varghese,Carlos G. Vanoye,Kristen Springer,Kristen L. Park,Jim Johnson,Scotty Sims,Zhigang Ji,Ana G. Chavez,Miranda J. Jankovic,Bereket Habte,Aamir R Zuberi,Cathleen M Lutz,Zhao Wang,Vaishnav Krishnan,Lisa Dudler,Stephanie Einsele-Scholz,Jeffrey L Noebels,Alfred L George,Atul Maheshwari,Anastasios Tzingounis,Edward Cooper

DOI: https://doi.org/10.1101/2024.01.04.574177

2024-06-26

Abstract:variants in children with neurodevelopmental impairment are difficult to assess due to their heterogeneity and unclear pathogenic mechanisms. We describe a child with neonatal-onset epilepsy, developmental impairment of intermediate severity, and KCNQ2 G256W heterozygosity. Analyzing prior KCNQ2 channel cryoelectron microscopy models revealed G256 as a node of an arch-shaped non-covalent bond network linking S5, the pore turret, and the ion path. Co-expression with G256W dominantly suppressed conduction by wild-type subunits in heterologous cells. Ezogabine partly reversed this suppression. G256W/+ mice have epilepsy leading to premature deaths. Hippocampal CA1 pyramidal cells from G256W/+ brain slices showed hyperexcitability. G256W/+ pyramidal cell KCNQ2 and KCNQ3 immunolabeling was significantly shifted from axon initial segments to neuronal somata. Despite normal mRNA levels, G256W/+ mouse KCNQ2 protein levels were reduced by about 50%. Our findings indicate that G256W pathogenicity results from multiplicative effects, including reductions in intrinsic conduction, subcellular targeting, and protein stability. These studies provide evidence for an unexpected and novel role for the KCNQ2 pore turret and introduce a valid animal model of encephalopathy. Our results, spanning structure to behavior, may be broadly applicable because the majority of encephalopathy patients share variants near the selectivity filter.

Neuroscience

Geodesic diameter of sets defined by few quadratic equations and inequalities

KCNH2-3.1 Mediates Aberrant Complement Activation and Impaired Hippocampal-Medial Prefrontal Circuitry Associated with Working Memory Deficits.

Etiological involvement of KCND1 variants in an X-linked neurodevelopmental disorder with variable expressivity

Koolen-de Vries Syndrome causal gene is required for motile ciliogenesis

An Epilepsy-Associated CILK1 Variant Compromises KATNIP Regulation and Impairs Primary Cilia and Hedgehog Signaling

KCNT2-Related Disorders: Phenotypes, Functional, and Pharmacological Properties

A KCNC1 Variant Linked to Rett Syndrome Disrupts ER to Golgi Trafficking of Kv3.1 Channel

Patients with KCNH1-related intellectual disability without distinctive features of Zimmermann-Laband/Temple-Baraitser syndrome

Abdominal Pregnancy: Discussion, classification, and case presentation

CONSTITUTIVE OPENING OF THE Kv7.2 PORE ACTIVATION GATE CAUSES KCNQ2-DEVELOPMENTAL ENCEPHALOPATHY

Genetic and phenotypic heterogeneity in KIAA0753-related ciliopathies

Asymmetric Michael reactions catalyzed by a highly efficient and recyclable quaternary ammonium ionic liquid-supported organocatalyst in aqueous media.

Altered neurological and neurobehavioral phenotypes in a mouse model of the recurrent KCNB1-p.R306C voltage-sensor variant

Metabolism of 12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid (12(R)-HETE) in corneal tissues: formation of novel metabolites.

Improved classification and pathogenicity assessment by comprehensive functional studies in a large data set of KCNQ2 variants

Both Gain- and Loss-of-function Variants of KCNA1 Are Associated with Paroxysmal Kinesigenic Dyskinesia.

NEK1 haploinsufficiency impairs ciliogenesis in human iPSC-derived motoneurons and brain organoids

Kctd7 deficiency induces myoclonic seizures associated with Purkinje cell death and microvascular defects

Familial KCNQ2 mutation: a psychiatric perspective

Plural molecular and cellular mechanisms of pore domain KCNQ2 encephalopathy